Michelle S Malane, M.D. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1781 Highland Ave, Cheshire, CT 06410 Phone: 203-272-3376 Fax: 203-272-9539 |
Dr. Frank Anthony Santoro, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1781 Highland Ave, Suite 106, Cheshire, CT 06410 Phone: 203-694-5857 Fax: 203-694-5616 |
Dr. Dana M Correale, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 677 S Main St, Cheshire, CT 06410 Phone: 203-250-7577 Fax: 203-250-0739 |
Dr. Paula Michele Bevilacqua, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 677 S Main St, Cheshire, CT 06410 Phone: 203-250-7577 Fax: 203-250-0739 |
News Archive
"For a long time, perceptions of Pakistan as a conservative Muslim country encouraged a belief that HIV/AIDS incidence would be non-existent or very low," but "with the number of HIV cases rising, the government finally included it in its 2009 national health policy," BBC News reports.
A new pediatric influenza vaccine that contains no preservatives - the only influenza vaccine approved for use in children 6 to 35 months of age - has been produced by the sanofi-aventis Group, in time for the 2005-2006 influenza season.
A newly published study in the Lancet suggested that a first-line treatment regimen including Zometa (zoledronic acid) significantly improved overall survival and progression-free survival in newly diagnosed multiple myeloma patients compared with a regimen that included oral clodronate. The impact on survival was independent of the effect of Zometa on bone complications (also known as skeletal-related events or SREs).
The (Torrance, Calif.) Daily Breeze: "With health care reform on the way - bringing with it scores of new Medi-Cal patients - community clinics that treat mostly low-income and uninsured patients are looking at ways to transform into primary care medical hubs. South Bay Family Health Care, based in Redondo Beach, will get help doing that from Los Angeles County's only public health insurance plan, L.A. Care. The nonprofit health plan has hired a consulting firm to help 11 clinics improve their treatment model over the next two years" (Evans, 10/28).
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 5 days ago